Appropriateness of medications prescribed to elderly patients with advanced heart failure and limited life expectancy who died during hospitalization

Drugs and Aging

Volumn 31, Issue 7, 2014, Pages 541-546

  Barceló, Montserrat ^a   Torres, Olga ^a   Ruiz, Domingo ^a   Casademont, Jordi ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALDOSTERONE ANTAGONIST; ANALGESIC AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; ANTITHROMBOCYTIC AGENT; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHLORPROPAMIDE; CHOLINESTERASE INHIBITOR; CLOPIDOGREL; CORTICOSTEROID; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FENTANYL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IRON; LOOP DIURETIC AGENT; MEMANTINE; MORPHINE; OPIATE; SEROTONIN UPTAKE INHIBITOR; THIAZIDE DIURETIC AGENT; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT; VERAPAMIL; VITAMIN;

AGED; ANTICOAGULANT THERAPY; ARTICLE; CHARLSON COMORBIDITY INDEX; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMAN; INAPPROPRIATE PRESCRIBING; IRON THERAPY; KARNOFSKY PERFORMANCE STATUS; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRESCRIPTION; PRIORITY JOURNAL; PROGNOSIS; PROPHYLAXIS; SURVIVAL RATE; TERTIARY CARE CENTER; DRUG USE; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

AGED; AGED, 80 AND OVER; DRUG UTILIZATION REVIEW; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMANS; LIFE EXPECTANCY; MALE;

EID: 84903782175     PISSN: 1170229X     EISSN: 11791969     Source Type: Journal    
DOI: 10.1007/s40266-014-0183-3     Document Type: Article

References (24)

1. Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013; 128:e240-7; originally published online June 5, doi:10.1161/CIR.0b013e31829e8776.
2. Salpeter SR, Luo EJ, Malter DS, et al. Systematic review of noncancer presentations with a median survival of 6 months or less. Am J Med. 2012; 125 (5):512.e1-16.
3. Cruz-Jentoft A, Boland B, Rexach L. Drug therapy optimization at the end of life. Drugs Aging. 2012;29(6):511-21.
4. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-83. (Pubitemid 17055592)
5. Katz S, Ford AB, Moskowitz RW, et al. Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychological function. JAMA. 1963;185:914-9.
6. Schag CC, Heinrich RL, Ganz PA. Karnofsky performance status revisited: reliability, validity and guidelines. J Clin Oncol. 1984;2(3):187-93. (Pubitemid 14138407)
7. McKee PA, Castelli WP, McNamara PM, et al. The natural history of congestive heart failure: the Framingham study. N Engl J Med. 1971;285(26):1441-6.
8. Delgado E, Muñoz M, Montero B, et al. Prescripción inapropiada de medicamentos en los pacientes mayores: los criterios STOPP/START. Rev Esp Geriatr Gerontol. 2009;44(5):273-9.
9. Mannucci PM. Thromboprophylaxis in the oldest old with atrial fibrillation: between Scylla and Charybdis. Eur J Intern Med. 2013;24:285-7.
10. O'Brien CP. Withdrawing medication. Managing medical comorbidities near the end of life. Can Fam Phys. 2011; 57:304-7.
11. McMurray JJV, Adamopoulos S, Anker SD, et al. Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC. Eur Heart J. 2012;33:1787-847.
12. O'Mahony D, O'Connor M. Pharmacotherapy at the end of life. Age Ageing. 2011;40:419-22.
13. Captopril Multicenter Research Group. A placebo-controlled trial of captopril in refractory chronic congestive heart failure. J Am Coll Cardiol. 1983;2:755-63.
14. Holmes HM, Hayley DC, Alexander GC, et al. Reconsidering medications appropriateness for patients late in life. Arch Intern Med. 2006;166:605-9.
15. Binaray C, Califf RM, Hasselblad V, et al. ESCAPE investigators and ESCAPE study coordinators. Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness: the ESCAPE trial. JAMA. 2005;294:1625-33.
16. Goodlin SJ. Palliative care in congestive heart failure. J Am Coll Cardiol. 2009;54:386-96.
17. Lee SJ, Leipzig RM, Walter LC. Incorporating lag time to benefit into prevention decisions for older adults. JAMA. 2013;310(24): 2609-10.
18. Levy WC, Mozaffarian D, Linker DT, et al. The Seattle heart failure model: prediction of survival in heart failure. Circulation. 2006;113:1424-33. (Pubitemid 43739439)
19. Aaronson KD, Schwartz JS, Chen TM, et al. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation. 1997;95:2660-7. (Pubitemid 27255495)
20. Fonarow GC, Adams KF Jr, Abraham WT, ADHERE Scientific Advisory Committee, Study Group, and Investigators, et al. Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA. 2005;293:572-80. (Pubitemid 40171239)
21. Lee DS, Austin PC, Rouleau JL, et al. Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. JAMA. 2003;290:2581-7. (Pubitemid 37443288)
22. O'Connor CM, Hasselblad V, Mehta RH, et al. Triage after hospitalization with advanced heart failure: the ESCAPE (Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness) risk model and discharge score. J Am Coll Cardiol. 2010;55:872-8.
23. Allen L, Co-Chair MHS, et al. Decision making in advanced heart failure. Circulation. 2012;125:1928-52.
24. Gómez-Batiste X, Martinez-Muñoz M, Blay C, et al. Proyecto NECPAL CCOMS-ICO©: Instrumento para la identificación de personas en situación de enfermedad crónica avanzada y necesidad de atención paliativa en servicios de salud y sociales. Centro colaborador de la OMS para programas públicos de curas paliativas. Institut Català d'Oncologia. Available at http://www.iconcologia.net.